INTRODUCTION
Adolescent girls and young women (AGYW) in sub‐Saharan Africa (SSA) account for roughly 25% of new HIV acquisitions while comprising only 10% of the population [Barriers to oral PrEP use among cisgender AGYW exist across socio‐ecological levels, including low‐risk perception, daily pill burden and side effects; challenges with disclosure to and support from key influencers; limited community awareness and stigma; and clinic accessibility, stock‐outs and negative provider attitudes [In the MTN‐034 